{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:31:54Z","timestamp":1784871114310,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Bohring-Opitz syndrome (BOS) is a rare genetic disease first reported by Bohring et al. in 1999. With the recent development of exome sequencing (ES), <jats:italic>de novo<\/jats:italic> truncating mutations in the additional sex-combs-like 1 (<jats:italic>ASXL1<\/jats:italic>) gene have been causally implicated in BOS. Herein, we describe a 7-month-old girl with intrauterine growth restriction, severe pulmonary infection, seizures, and craniofacial abnormalities (microcephaly, micro\/retrognathia, hypertelorism, depressed nasal bridge, low-set ears and hypertrichosis) at birth. At a later stage, the patient developed global developmental delay. We performed ES and identified a <jats:italic>de novo<\/jats:italic> heterozygous mutation in <jats:italic>ASXL1<\/jats:italic>, namely, c.1210C&amp;gt;T\/p.R404<jats:sup>*<\/jats:sup>. However, this case did not have trigonocephaly, facial hemangioma, prominent eyes, myopia, BOS posture, or brain abnormalities (enlarged subarachnoid spaces, agenesis of the corpus callosum, moderately enlarged cerebral ventricles, or prominent frontal subarachnoid spaces), which are common characteristics in most patients with BOS-harboring <jats:italic>ASXL1<\/jats:italic> mutations. These new data expand the phenotype of BOS driven by <jats:italic>ASXL1<\/jats:italic> and may assist in more accurately delineating the phenotypes caused by variants of this gene.<\/jats:p>","DOI":"10.3389\/fped.2021.678615","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:30:01Z","timestamp":1630686601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A de novo Variant of ASXL1 Is Associated With an Atypical Phenotype of Bohring-Opitz Syndrome: Case Report and Literature Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Weiqing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xike","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/(sici)1096-8628(19990827)85:5<438::aid-ajmg2>3.0.co;2-a","article-title":"Severe end of opitz trigonocephaly (C) syndrome or new syndrome?","volume":"85","author":"Bohring","year":"1999","journal-title":"Am J Med Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ejhg.2010.234","article-title":"Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis","volume":"19","author":"Hastings","year":"2011","journal-title":"Eur J Hum Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ng.868","article-title":"De novo nonsense mutations in ASXL1 cause bohring-opitz syndrome","volume":"43","author":"Hoischen","year":"2011","journal-title":"Nat Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2009-07-230698","article-title":"Loss-of-function additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia","volume":"115","author":"Fisher","year":"2010","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Gelsi-Boyer","year":"2012","journal-title":"J Hematol Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.stemcr.2016.04.013","article-title":"Loss of Asxl1 alters self-renewal and cell fate of bone marrow stromal cell, leading to bohring-opitz-like syndrome in mice","volume":"6","author":"Zhang","year":"2016","journal-title":"Stem Cell Rep."},{"key":"B7","first-page":"121","article-title":"A case report of Bohring-Opitz syndrome","volume":"30","author":"Lin","year":"2020","journal-title":"China Health Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"104155","DOI":"10.1016\/j.ejmg.2021.104155","article-title":"Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome","volume":"64","author":"Zhao","year":"2021","journal-title":"Eur J Med Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/MCD.0000000000000126","article-title":"A novel de-novo frameshift mutation of the ASXL1 gene in a classic case of Bohring-Opitz syndrome","volume":"25","author":"Arunachal","year":"2016","journal-title":"Clin Dysmorphol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ajmg.a.38681","article-title":"Lethal persistent pulmonary hypertension of the newborn in Bohring-Opitz syndrome","volume":"176","author":"Kibe","year":"2018","journal-title":"Am J Med Genet A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ccr3.1603","article-title":"The ASXL1 mutation p","volume":"6","author":"Urreizti","year":"2018","journal-title":"Clin Case Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"543528","DOI":"10.3389\/fgene.2020.543528","article-title":"Genomic Analysis of Korean patient with microcephaly","volume":"11","author":"Lee","year":"2020","journal-title":"Front Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/humu.23203","article-title":"Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz syndrome","volume":"38","author":"Carlston","year":"2017","journal-title":"Hum Mutat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B15","first-page":"98","article-title":"A de novo truncating mutation in ASXL1 associated with segmental overgrowth","author":"Efthymiou","year":"2019","journal-title":"J Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00439-019-01985-y","article-title":"Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders","volume":"138","author":"Negri","year":"2019","journal-title":"Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/ajmg.a.38259","article-title":"A rapid gene sequencing panel strategy to facilitate precision neonatal medicine","volume":"173","author":"Brunelli","year":"2017","journal-title":"Am J Med Genet A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.24251","article-title":"Clinical whole exome sequencing in child neurology practice","volume":"76","author":"Srivastava","year":"2014","journal-title":"Ann Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1002\/ajmg.a.37342","article-title":"Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: review of the most prevalent molecular and phenotypic features of the syndrome","author":"Dangiolo","year":"2015","journal-title":"Am J Med Genet A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ajmg.a.38686","article-title":"Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother","volume":"176","author":"Bedoukian","year":"2018","journal-title":"Am J Med Genet A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/ajmg.a.37131","article-title":"Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance","author":"Russell","year":"2015","journal-title":"Am J Med Genet A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ajmg.a.61397","article-title":"Extending the phenotypic spectrum of Bohring-Opitz syndrome: mild case confirmed by functional studies","volume":"182","author":"Leon","year":"2020","journal-title":"Am J Med Genet A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.a.37418","article-title":"Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes","author":"Urreizti","year":"2016","journal-title":"Am J Med Genet A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/mcs.a004846","article-title":"The tale of two genes: from next-generation sequencing to phenotype","author":"Rohanizadegan","year":"2020","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"B25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ajmg.a.35265","article-title":"Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations","author":"Magini","year":"2012","journal-title":"Am J Med Genet A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ajmg.a.62156","article-title":"Understanding the phenotypic spectrum of ASXL-related disease: ten cases and a review of the literature","volume":"185","author":"Cuddapah","year":"2021","journal-title":"Am J Med Genet A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.7534\/j.issn.1009-2137.2014.04.057","article-title":"[Role of ASXL1 mutation in myeloid malignancies]","volume":"22","author":"Sheng","year":"2014","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia."},{"key":"B29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.stemcr.2019.03.006","article-title":"Pathological ASXL1 mutations and protein variants impair neural crest development","volume":"12","author":"Matheus","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2013.281","article-title":"Functional and cancer genomics of ASXL family members","volume":"109","author":"Katoh","year":"2013","journal-title":"Br J Cancer."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.678615\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:30:05Z","timestamp":1630686605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.678615\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":30,"alternative-id":["10.3389\/fped.2021.678615"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.678615","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"article-number":"678615"}}